FR EA

Contract analysis

Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.

Contract analysis / email-reyes-to-kwon-mfn-resolution.eml
email-reyes-to-kwon-mfn-resolution.eml
1009-00001 · 28 clauses
High · 2 Medium · 5 Standard · 1
From: Nina Reyes <nreyes@calderwoodharkness.com>
From: Nina Reyes <nreyes@calderwoodharkness.com> To: Danielle Kwon <dkwon@whitfieldprattsoo.com> Cc: Leonard Ashford <lashford@calderwoodharkness.com> Date: Sat, 06 Jan 2024 03:47:00 -0000 Subject: RE: Skybridge Fintech Ltd. — Convertible Note Financing — Resolution of MFN and Information Rights Open Points
Thank you for your email and for the productive call earlier today with you, Graham, Leona
Thank you for your email and for the productive call earlier today with you, Graham, Leonard, and me to work through the remaining open points on the Note Purchase Agreement. I wanted to memorialize our discussion and confirm the agreed resolutions on the two outstanding substantive issues: (i) the scope of the Information Rights provision under Section 4.3 of the NPA and (ii) the Most Favored Nation provision under
With these points now resolved, we believe the NPA should be in substantially final form f
With these points now resolved, we believe the NPA should be in substantially final form for circulation to all parties and their respective clients for final review ahead of the targeted signing date of January 15, 2024. A summary of the agreed positions follows below, and I have attached revised redlines of both sections against the second revised draft of the NPA circulated on January 4, 2024.
As background, your firm (on behalf of Ridgeline Ventures Fund IV, L.P. and the broader in Standard
⚑ Commercial term
As background, your firm (on behalf of Ridgeline Ventures Fund IV, L.P. and the broader investor syndicate) had requested that all Purchasers under the NPA — including Northstar Innovation Fund II, L.P., which as a new investor committing $10,000,000 of the $60,000,000 aggregate principal amount is not currently a party to the Amended and Restated Investors' Rights Agreement — receive the same suite of information ri
Following our discussion, the parties agreed to the following framework:
Following our discussion, the parties agreed to the following framework:
1. **Major Noteholder Information Rights.** All Purchasers holding Notes with an aggregate Medium
⚑ Notice / time limit to track
1. **Major Noteholder Information Rights.** All Purchasers holding Notes with an aggregate original principal amount of at least $5,000,000 (each, a "Major Noteholder") will receive: (a) quarterly unaudited financial statements (balance sheet, income statement, and statement of cash flows) within 45 days following the end of each fiscal quarter; and (b) annual audited financial statements, audited by Pinnacle Audit G
2. **Annual Operating Budget.** Major Noteholders will also receive a copy of the Company' Medium
⚑ Notice / time limit to track
2. **Annual Operating Budget.** Major Noteholders will also receive a copy of the Company's annual operating budget within 30 days following the start of each fiscal year.
3. **Material Adverse Change Notice.** All Purchasers, regardless of whether they meet the Medium
⚑ Notice / time limit to track
3. **Material Adverse Change Notice.** All Purchasers, regardless of whether they meet the Major Noteholder threshold, will receive prompt written notice of any material adverse change in the Company's business, financial condition, or operations.
4. **Termination.** The information rights granted under Section 4.3 will terminate automa High
⚑ Non-compete / exclusivity restraint
4. **Termination.** The information rights granted under Section 4.3 will terminate automatically upon conversion of the Notes into equity securities of the Company (whether upon a Qualified Financing at the $80,000,000 threshold or otherwise), at which point each holder's information rights will be governed exclusively by Amendment No. 1 to the Amended and Restated Investors' Rights Agreement.
5. **Confidentiality.** The Company retains the right to require each Purchaser to execute Medium
⚑ Confidentiality undertaking
5. **Confidentiality.** The Company retains the right to require each Purchaser to execute a reasonable confidentiality and non-disclosure undertaking as a condition to receiving financial information under this section, consistent with the confidentiality provisions currently in effect under the IRA.
The revised Section 4.3 language reflecting this agreement is set forth in the attached re
The revised Section 4.3 language reflecting this agreement is set forth in the attached redline (Attachment 1).
**Section 5.7 — Most Favored Nation (MFN)**
**Section 5.7 — Most Favored Nation (MFN)**
As you know, Ridgeline had proposed a broad MFN provision under which any subsequent conve
As you know, Ridgeline had proposed a broad MFN provision under which any subsequent convertible note, SAFE, or other convertible instrument issued by Skybridge on terms more favorable than those in the Notes (bearing interest at 6.00% per annum, a $750,000,000 valuation cap, and a 20% conversion discount) would trigger an automatic right for existing Noteholders to elect to amend their Notes to incorporate such more
Following our discussion, the parties agreed to the following:
Following our discussion, the parties agreed to the following:
1. **Scope.** The MFN provision applies to any convertible promissory note, SAFE, or simil
1. **Scope.** The MFN provision applies to any convertible promissory note, SAFE, or similar convertible debt or equity instrument issued by the Company after the date of the NPA and prior to a Qualified Financing.
2. **Definition of "More Favorable Terms."** For purposes of the MFN, "more favorable term
2. **Definition of "More Favorable Terms."** For purposes of the MFN, "more favorable terms" means a lower valuation cap, a greater conversion discount, a higher interest rate, more favorable change of control provisions, or other economic terms that are, taken as a whole, more favorable to the holder of such subsequent instrument than those set forth in the Notes.
3. **Carve-Outs.** The MFN will not apply to: (a) issuances of equity securities in a Qual Medium
⚑ Liability cap to check against exposure
3. **Carve-Outs.** The MFN will not apply to: (a) issuances of equity securities in a Qualified Financing; (b) issuances of equity securities pursuant to the Company's equity incentive plan, including stock options, restricted stock units, and similar equity awards approved by the Board of Directors; (c) issuances in connection with bona fide strategic or commercial partnerships approved by the Board of Directors, pr
4. **Notice and Election.** Upon the issuance of any instrument that would trigger the MFN
4. **Notice and Election.** Upon the issuance of any instrument that would trigger the MFN, the Company must provide written notice to all Noteholders within 10 business days of such issuance, together with a copy of the instrument and its material terms (subject to redaction of commercially sensitive counterparty information not relevant to the economic terms). Each Noteholder will then have 15 business days followi
5. **Non-Transferability.** The MFN election right is personal to each original Purchaser
5. **Non-Transferability.** The MFN election right is personal to each original Purchaser and is not transferable, except in connection with a permitted transfer of the Note itself in accordance with the transfer restrictions set forth in the NPA.
The revised Section 5.7 language reflecting this agreement is set forth in the attached re
The revised Section 5.7 language reflecting this agreement is set forth in the attached redline (Attachment 2).
I will circulate a revised clean draft and blackline of the full NPA incorporating the agr
I will circulate a revised clean draft and blackline of the full NPA incorporating the agreed Section 4.3 and Section 5.7 language to all parties by end of day Monday, January 8, 2024. In the meantime, I would appreciate it if you and Graham could confirm by reply email that the attached redlines accurately reflect the agreement reached on today's call, so that Leonard and I can begin preparing the near-final executi
For the benefit of all parties on copy, the remaining procedural and closing workstreams c
For the benefit of all parties on copy, the remaining procedural and closing workstreams continue to track separately:
- **Board Consent:** A draft of the Board written consent authorizing the issuance of the
- **Board Consent:** A draft of the Board written consent authorizing the issuance of the Notes and the transactions contemplated by the NPA will be circulated tomorrow, January 7, with a target execution date of January 10, 2024. - **Stockholder Written Consent:** To follow upon Board approval. - **Kelvantis Lender Consent:** As you are aware, a consent request under the Loan and Security Agreement dated August 15,
Danielle and Graham, thank you again for your constructive approach in resolving these poi
Danielle and Graham, thank you again for your constructive approach in resolving these points efficiently. We are pleased to have the substantive terms aligned and look forward to moving toward execution on schedule.
**Nina Reyes**
**Nina Reyes** Senior Associate Emerging Companies & Venture Capital Calderwood & Harkness LLP 600 Lexington Avenue New York, NY 10022 D: (212) 554-7183 E: nreyes@calderwoodharkness.com
Matter Ref.: Skybridge Fintech Ltd. — Convertible Note Bridge Financing (Matter No. 1009-0
Matter Ref.: Skybridge Fintech Ltd. — Convertible Note Bridge Financing (Matter No. 1009-00001)
**Attachments:**
**Attachments:** 1. Revised Section 4.3 (Information Rights) — Redline v. Second Revised NPA Draft (Jan. 4, 2024) [.docx] 2. Revised Section 5.7 (Most Favored Nation) — Redline v. Second Revised NPA Draft (Jan. 4, 2024) [.docx]
*CONFIDENTIALITY NOTICE: This email and any attachments are for the exclusive and confiden High
⚑ Non-compete / exclusivity restraint
*CONFIDENTIALITY NOTICE: This email and any attachments are for the exclusive and confidential use of the intended recipient. This communication may contain information that is privileged, confidential, and exempt from disclosure under applicable law, including attorney-client privilege and attorney work product doctrine. If you are not the intended recipient, any use, dissemination, distribution, or copying of this